Additionally, CHI3L1 plays a significant role in CD4+ T cell development and T helper 2 (Th2)-mediated inflammation, while CHI3L1 decreases responses of Th1 and cytotoxic CD8+ T cells during cancer progression 2. Here, CD8A is linked to cancer.